Chemoprevention in breast cancer.
Vogel
Victor
V
D000367:Age Factors; D000730:Androstadienes / Q000191:economics / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000191:economics / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000191:economics / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000191:economics / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D002278:Carcinoma in Situ / Q000191:economics / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D018275:Carcinoma, Lobular / Q000191:economics / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013629:Tamoxifen / Q000191:economics / Q000627:therapeutic use
D000730:Androstadienes; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D013629:Tamoxifen; C056516:exemestane